Compound Detail
CHEMBL4089422
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL4089422 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | RQNCWCGCWQYWQA-UHFFFAOYSA-N |
1
Targets
2
Activities
1
Assay Types
0
PK Parameters
3
Publications
0
Known Names
Molecular Properties
396.4
MW (Da)
2.50
ALogP
7
HBA
2
HBD
86.4
PSA (Ų)
0.69
QED
0
Ro5 Violations
5
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 2 meas. best 4.25
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| HepG2 CHEMBL395 | IC50 | 4.25 | 4.25 | 56234.1 | 2 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| HepG2 | IC50 | = | 56560.0 | nM | 4.25 | Cytotoxicity against human HepG2 cells assessed as reduction in cell viability a... | 28117202 |
| HepG2 | IC50 | = | 56234.13 | nM | 4.25 | Cytotoxicity against human HepG2 cells assessed as reduction in cell viability a... | 28117202 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 28117202 | 10.1016/j.bmcl.2016.12.076 | HepG2 | 2 |
| 28117202 | 10.1016/j.bmcl.2016.12.076 | A549 | 1 |
| 28117202 | 10.1016/j.bmcl.2016.12.076 | Unchecked | 1 |
Data from ChEMBL 36 via Core Engine